Spravato is an FDA-approved esketamine nasal spray used for adults with treatment-resistant depression. It works differently from traditional antidepressants and is administered in a controlled clinical setting.
Overview
At Aspire Clinic, we are proud to offer the innovative and effective treatment option of Spravato. This nasal spray has been approved by the FDA as a safe and effective treatment for depression, and is administered in a clinical setting under the supervision of a healthcare professional. Spravato works by increasing the levels of glutamate in the brain, which can help to relieve symptoms of depression and improve overall mental well-being.
Who This Service Is For
- Adults with treatment-resistant depression
- Patients who have not responded to standard medications
How Treatment Works
Spravato is administered under medical supervision, followed by monitoring to ensure safety and effectiveness. Treatment occurs in structured sessions.
What to Expect
- In-clinic administration
- Medical supervision throughout treatment
- Post-treatment monitoring
